ORIGINAL RESEARCH article
Front. Pediatr.
Sec. Neonatology
Volume 13 - 2025 | doi: 10.3389/fped.2025.1643333
Association between fentanyl use and reduced risk of tension pneumothorax in extremely preterm infants born at 22–23 weeks' gestation: A retrospective case–control study
Provisionally accepted- Kagoshima City Hospital, Kagoshima, Japan
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Tension pneumothorax is a life-threatening complication in extremely preterm infants, especially within the first 72 hours of life. Identifying preventive strategies is crucial to improving survival rates. This study aimed to evaluate the association between fentanyl use and the incidence of tension pneumothorax in extremely preterm infants born at 22–23 weeks of gestation. Methods: This retrospective case–control study was conducted at a tertiary care center in Japan. It included 138 preterm infants with a gestational age from 22 weeks + 0 days to 23 weeks + 6 days (January 2010 to March 2023). Logistic regression and propensity score matching were used to adjust for confounding factors such as chorioamnionitis stage 2-3, oligohydramnios, antenatal steroids, ventilation mode, persistent pulmonary hypertension, and birth at a primary or secondary perinatal center. Results: Sixteen infants (11.6%) developed tension pneumothorax within 72 h of birth, with a mortality rate of 68.7%. The use of fentanyl was associated with a reduced risk of tension pneumothorax (adjusted odds ratio: 0.1; 95% confidence interval: 0.01–0.75). Conclusion: The use of fentanyl may reduce the risk of tension pneumothorax within the first 72 h of life in infants born at 22–23 weeks of gestation. Further randomized controlled trials are needed to validate these findings and assess long-term outcomes.
Keywords: tension pneumothorax, Extremely preterm infants, Fentanyl, 22–23 weeks of gestation, thefirst 72 hours of life
Received: 08 Jun 2025; Accepted: 11 Sep 2025.
Copyright: © 2025 Kurimoto, Takuya, Ohashi, Hirakawa, Kibe, Maeda and Kamitomo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Tomonori Kurimoto, Kagoshima City Hospital, Kagoshima, Japan
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.